The Role of Digital Medicine in Autism Spectrum Disorder Clinical - - PowerPoint PPT Presentation

the role of digital medicine in autism spectrum disorder
SMART_READER_LITE
LIVE PREVIEW

The Role of Digital Medicine in Autism Spectrum Disorder Clinical - - PowerPoint PPT Presentation

The Role of Digital Medicine in Autism Spectrum Disorder Clinical Trials Gahan J. Pandina, PhD ISCTM-ECNP Joint Autumn Conference 6 September 2019 Copenhagen, Denmark Disclosures Full time employee of Janssen Research &


slide-1
SLIDE 1

Gahan J. Pandina, PhD

ISCTM-ECNP Joint Autumn Conference ▪ 6 September 2019 ▪ Copenhagen, Denmark

The Role of Digital Medicine in Autism Spectrum Disorder Clinical Trials

slide-2
SLIDE 2

Disclosures

  • Full time employee of Janssen Research & Development LLC
  • Johnson & Johnson Stockholder
  • The opinions expressed in this presentation are those of Dr. Pandina,

not Janssen or Johnson & Johnson

2

slide-3
SLIDE 3

Agenda

3

  • Role of digital medicine in ASD clinical trials
  • Digital data collection – strengths and challenges
  • Sample sensor data / correlation with clinical results
  • Complex analytic approaches
  • Conclusions
slide-4
SLIDE 4

Digital Medicine and ASD Clinical Trials

4

Zhang et al (2018). Digital medicine: Emergence, definition, scope, and future. Digit Med, 4:1-4.

Describes the intersection of autism assessment, diagnosis, and intervention and digital technologies

Health-based video games Wearables and trackers Electronic health records Other Biosensors Web-and-mobile apps

slide-5
SLIDE 5

Digital Medicine and ASD Clinical Trials

5

Zhang et al (2018). Digital medicine: Emergence, definition, scope, and future. Digit Med, 4:1-4.

Describes the intersection of autism assessment, diagnosis, and intervention and digital technologies

Academia, Sites, Foundations, Sponsor Companies Regulatory Agencies CROs & Partners Health-based video games Wearables and trackers Electronic health records Other Biosensors Web-and-mobile apps

INTEGRATION

slide-6
SLIDE 6

Digital Medicine and ASD Clinical Trials

6

Zhang et al (2018). Digital medicine: Emergence, definition, scope, and future. Digit Med, 4:1-4.

Describes the intersection of autism assessment, diagnosis, and intervention and digital technologies

Academia, Sites, Foundations, Sponsor Companies Regulatory Agencies CROs & Partners Health-based video games Wearables and trackers Electronic health records Other Biosensors Web-and-mobile apps

INTEGRATION

Biomarkers & Other Endpoints

PoC Participant Selection Change Measurement Population Stratification

slide-7
SLIDE 7

Use of Digital Medicine in ASD Clinical Trials

Strengths and Challenges

7

Zhang et al (2018). Digital medicine: Emergence, definition, scope, and future. Digit Med, 4:1-4.

Capture of digital endpoints – vs. standard paper rating scales Strengths Capture data in real time Central tracking Reduced burden of data entry, scoring Reduced data errors / loss Optimize point-of-collection (clinical site, home, etc.) Pre-programmed queries/skip-outs (no “maybe”) Full audit trail / data QC Maintain control over comments and writing in the margin Passive, “automatic” data capture Challenges Cost of development, implementation, and maintenance

  • Hardware, software

Site and participant training, support, and account management Managing a compliant, global framework Back-up approach in case of problems

slide-8
SLIDE 8

8

*Please note that JAKE is for research use only **Ness et al (2019). Frontiers Neurosci: 13:111. https://doi.org/10.3389/fnins.2019.00111

Overview - Janssen Autism Knowledge Engine*

**

slide-9
SLIDE 9

Autism Biomarker Study Design

9

Ness et al (2019). Frontiers Neurosci: 13:111. https://doi.org/10.3389/fnins.2019.00111

Key Inclusion/ Exclusion

  • Individuals with a diagnosis of ASD
  • Aged 6 years to adult
  • 9 US centers
  • IQ of 60+
  • Ongoing behavioral and pharmacologic

therapies allowed

  • English speaking
  • Capable of participation in study procedures

N=144 ASD Treatment

  • No restrictions on concurrent therapies
  • 3 site visits w/ BSWB (BL, Wk 4, Endpoint)

14-day Screening Phase

8 or 10 Week Prospective Monitoring N=41: Typically Developing Controls

  • BSWB, rating scales, single assessment

Single visit 8-10 weeks

ASD TD N 144 41 Male le 112 (77.8) 27 (65.9) Mea ean Age e (SD (SD) 14.58 (7.83) 16.27 (13.176)

slide-10
SLIDE 10

Autism Behavior Inventory (ABI; v1.1)

10

1 Bangerter et al (2019). J Autism Dev Disorders, online at https://doi.org/10.1007/s10803-019-03965-7 2 Data on file

Core Domains Associated Domains

5 Symptom Domains

Moo

  • od &

& Anx nxie iety

  • 62

62-item scale le (mon (monthly ly)

  • 24

24-item Sh Short

  • rt form
  • rm (bi

(bi-weekly ly)

  • Ra

Rated 0 to

  • 3 (0

(0 to

  • ma

max.)

Self lf Regula latio ion Chall allenging Behavior

  • rs

Soc

  • cia

ial l Com

  • mmunic

icatio ion Restric icted Behavior

  • r

ABI

ABI / Other Scale Domain

  • Correl. (r)

ABI Core --- SRS Total 0.81 ABI-RRB --- RBSR Total 0.76 ABI-RRB --- SRS RI, RB 0.75 ABI-SC --- SRS SC, I 0.66 ABI / Other Scale Domain

  • Correl. (r)

ABI-MA --- CASI Anxiety 0.77 ABI-SR --- ABC Hyper, NonCom 0.88 ABI-SR --- ABC Inapp Speech 0.64 ABI-CB --- ABC Irritability 0.76

slide-11
SLIDE 11

11

Visual Exploration Test

Manyakov et al (2018). Autism Research 11: 1554-1566.

11

slide-12
SLIDE 12

12

Visual Exploration Test – Broad Differences in ASD vs. TD

Exploration (#/% valid time)

  • Less exploration of all images
  • Greater perseveration on high autism interest items
  • Perseveration on HAI items in both social and non-

social arrays P<0.001 Participants with ASD (vs. TD) showed significantly: Example: Exploration

Manyakov et al (2018). Autism Research 11: 1554-1566.

12

slide-13
SLIDE 13

13

Visual Exploration Test – Broad Differences in ASD vs. TD

Exploration (#/% valid time)

  • Less exploration of all images
  • Greater perseveration on high autism interest items
  • Perseveration on HAI items in both social and non-

social arrays P<0.001 Participants with ASD (vs. TD) showed significantly: Example: Exploration More complex features may tell us more about how visual perceptual processing affects social behavior … does combining variables or constructing new features result in better as biomarkers ? BUT…. Visual processing is a complex behavioral phenomenon!

Manyakov et al (2018). Autism Research 11: 1554-1566.

13

slide-14
SLIDE 14

14

Eye-Tracking Data May Benefit from More Complex Analytic Approach

RQA (Recurrence Quantification Analysis) approach to identify eye-tracking patterns

Manyakov et al (2018). Autism Research 11: 1554-1566.

14

slide-15
SLIDE 15

15

Eye-Tracking Data May Benefit from More Complex Analytic Approach

RQA (Recurrence Quantification Analysis) approach to identify eye-tracking patterns

Manyakov et al (2018). Autism Research 11: 1554-1566.

Recurrence Rate

Patterns and duration of refixations

Center of Recurrence Mass

Timing between fixations

Recurrent fixations close in time Recurrent fixations distant in time RR only RR and detail

  • rientation

Determinism

Repetitive patterns of gaze shift

Pairs of consecutive fixations Repeated shift between images

Laminarity

Fixation and rescanning pattern

Single fixation, then rescanned in detail Detailed first fixation, then quickly rescanned 15

slide-16
SLIDE 16

16

Eye-Tracking Data May Benefit from More Complex Analytic Approach

RQA (Recurrence Quantification Analysis) approach to identify eye-tracking patterns

Manyakov et al (2018). Autism Research 11: 1554-1566.

Recurrence Rate

Patterns and duration of refixations

Center of Recurrence Mass

Timing between fixations

Recurrent fixations close in time Recurrent fixations distant in time RR only RR and detail

  • rientation

Determinism

Repetitive patterns of gaze shift

Pairs of consecutive fixations Repeated shift between images

Laminarity

Fixation and rescanning pattern

Single fixation, then rescanned in detail Detailed first fixation, then quickly rescanned Statistically lower in ASD vs. TD, correlates to symptoms 16

slide-17
SLIDE 17

Funny Videos

Do individuals with ASD have an atypical affective response?

  • Measurement of spontaneous affective

response at time proximal to “event”

  • May be more relevant to social

exchange than prompted affect

  • Not perceived as “tests”
  • Appear to have durable response, even

with repetition

Bangerter et al. (submitted).

17

slide-18
SLIDE 18

18 1 Ban

angerter et al, al, in in pr preparation

Funny Videos – FACET Results

Differential spontaneous affective response in ASD subgroups

  • Wide variability in ASD affective

response to funny videos

  • ASD – 2 subgroups emerge
  • “Over-responders” (red)
  • “Under-responders” (blue)

Lip corner puller Cheek raiser

Bangerter et al. (submitted).

18

slide-19
SLIDE 19

19 1 Ban

angerter et al, al, in in pr preparation

Funny Videos – FACET Results

Differential spontaneous affective response in ASD subgroups

  • Wide variability in ASD affective

response to funny videos

  • ASD – 2 subgroups emerge
  • “Over-responders” (red)
  • “Under-responders” (blue)

Lip corner puller Cheek raiser

Under-responders (vs. TD group)*

  • AU6 avg: p <0.001, r = - 0.25
  • AU12 avg: p <0.001, r = - 0.36

*Linear regression (sex, age)

Over-responders (vs TD group)*

  • AU6 avg: p <0.001, r = 0.62
  • AU12 avg: p <0.001, r = 0.3

Bangerter et al. (submitted).

19

slide-20
SLIDE 20

Resting state EEG

  • Both eyes open (hourglass) and eyes closed conditions

Janssen Research & Development Confidential Janssen Research & Development – data in preparation

20

slide-21
SLIDE 21

EEG Power

Resting State, Eyes Open

Hypothesis

Wang et al. 2013

Results

Significant difference is seen mainly in Alpha at posterior regions

Preliminary results Janssen Research & Development – data in preparation

21

slide-22
SLIDE 22

EEG Power

Resting State, Eyes Open Correlation between alpha power and symptom severity (r~ -.21)

Preliminary results Janssen Research & Development – data in preparation

22

slide-23
SLIDE 23

EEG Asymmetry

Resting state, left/right spectral power (frontal) Eyes open, frontal region

delta gamma beta alpha theta

In ASD left/right asymmetry is higher than TD (ASD[left/right] < TD[left/right])

Preliminary results

Significant Not significant

Janssen Research & Development – data in preparation

23

slide-24
SLIDE 24

EEG regional connectivity in ASD vs. TD

Resting State, Eyes Closed Example: Theta, eyes closed ASD > TD: only connections (coherence) with sig. differences shown

  • dashed lines – p<0.1
  • solid lies – p<0.05)

In ASD, coherence between frontal and other regions is increased in α, θ, δ and decreased in β, γ (vs. TD)

Janssen Research & Development – data in preparation Preliminary results

24

slide-25
SLIDE 25

25

Data Reduction & Prediction

Analysis of JAKE Biosensor Workbench Data

25

Tasks Activity monitoring Biological motion Social orienting task Social vs. non-social videos NIMSTIM direct/averted gaze Visual exploration task Evoke potential responses Resting state Facial expression Funny videos Auditory stimuli

Jagannatha et al (2019). Stat Biopharm Res, DOI: 10.1080/19466315.2018.1527247

# Features 539 3738 972 4502 12741 859 2094 3626 342 684 1014 Total = 31,111

Eliminate near zero variance = 25,022 Eliminate Collinearity w/in each task = 9,705 Eliminate Collinearity across tasks = 3,827 Eliminate features missing >50% of data = 9,705 Imputation possible only w/ ~70% non-missing obsns = 2,569 Sensors = EEG, ECG, Eye- tracking, FACET, EDA

Top 20 Features explain 80% of ASD vs. TD variance

3 common variables

  • VET: ECG heart rate
  • VET: social images explored
  • Social videos: % face view

25

slide-26
SLIDE 26

Conclusions

  • ASD is complex, heterogeneity affects

development new, effective therapies

  • Digital medicine approaches may

streamline data collection (web, mobile), produce higher quality data

  • Biomarkers research should include single

major features, multiple features within tasks, and combination approaches

  • Sensor-based technologies may allow

more objective means of stratification and measurement of change

26

THANK YOU

Partners Michael Aman Geraldine Dawson Anna Esbensen Matthew Goodwin Robert Hendren KaiFai Ho Bennett Leventhal David Lewin Luke Mason Mark Opler Fred Shic Andrew Skalkin Janssen Abi Bangerter Matthew Boice Meenakshi Chatterjee Shyla Jagannatha Dzmitry Kaliukhovich Joseph Manfredonia Nikolay Manyakov Seth Ness